- Home
- Publications
- Publication Search
- Publication Details
Title
Factor XII(a) inhibitors: a review of the patent literature
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume -, Issue -, Pages 1-22
Publisher
Informa UK Limited
Online
2021-06-18
DOI
10.1080/13543776.2021.1945580
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in oligonucleotide drug delivery
- (2020) Thomas C. Roberts et al. NATURE REVIEWS DRUG DISCOVERY
- VE-1902—A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis
- (2020) Mohanram Sivaraja et al. THROMBOSIS RESEARCH
- Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
- (2020) Jonas Wilbs et al. Nature Communications
- Acylated 1H-1,2,4-Triazol-5-amines Targeting Human Coagulation Factor XIIa and Thrombin: Conventional and Microscale Synthesis, Anticoagulant Properties, and Mechanism of Action
- (2020) Marvin Korff et al. JOURNAL OF MEDICINAL CHEMISTRY
- Factor XII/XIIa inhibitors: Their discovery, development, and potential indications
- (2020) Clara Davoine et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function
- (2020) Jingxuan Liu et al. THROMBOSIS RESEARCH
- Hereditary angioedema: an update on causes, manifestations and treatment
- (2019) Hilary J Longhurst et al. BRITISH JOURNAL OF HOSPITAL MEDICINE
- Crystal structures of the recombinant β-factor XIIa protease with bound Thr-Arg and Pro-Arg substrate mimetics
- (2019) Monika Pathak et al. Acta Crystallographica Section D-Structural Biology
- Roles of Factor XII in Innate Immunity
- (2019) Thomas Renné et al. Frontiers in Immunology
- Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass
- (2019) Valérie Pireaux et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Coagulation factor XII in thrombosis and inflammation
- (2018) Coen Maas et al. BLOOD
- Antibody-mediated inhibition of FXIIa blocks downstream bradykinin generation
- (2018) Helen Cao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Factor XII in coagulation, inflammation and beyond
- (2018) Miroslava Didiasova et al. CELLULAR SIGNALLING
- Reversible covalent direct thrombin inhibitors
- (2018) Mohanram Sivaraja et al. PLoS One
- An investigational RNAi therapeutic targeting Factor XII (ALN-F12) for the treatment of hereditary angioedema
- (2018) Jingxuan Liu et al. RNA
- Peptide Macrocycle Inhibitor of Coagulation Factor XII with Subnanomolar Affinity and High Target Selectivity
- (2017) Simon J. Middendorp et al. JOURNAL OF MEDICINAL CHEMISTRY
- Alleviation of secondary brain injury, posttraumatic inflammation, and brain edema formation by inhibition of factor XIIa
- (2017) Sarah Hopp et al. Journal of Neuroinflammation
- Inhibition of Factors XI and XII for Prevention of Thrombosis Induced by Artificial Surfaces
- (2017) Benjamin Tillman et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
- (2017) Yuanyu Huang Molecular Therapy-Nucleic Acids
- siRNA Delivery Strategies: A Comprehensive Review of Recent Developments
- (2017) Katyayani Tatiparti et al. Nanomaterials
- Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis
- (2017) Lysann Bender et al. Frontiers in Immunology
- Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory DiseasesHighlights
- (2016) Katrin F. Nickel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis
- (2016) Frauke May et al. BRITISH JOURNAL OF HAEMATOLOGY
- Synthesis, evaluation and structure-activity relationship of new 3-carboxamide coumarins as FXIIa inhibitors
- (2016) Charlotte Bouckaert et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Factor 12 (F12) with a Novel RNAi Delivery Platform As a Prophylactic Treatment for Hereditary Angioedema (HAE)
- (2016) Stacey Melquist et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Factor XIIa as a Novel Target for Thrombosis: Target Engagement Requirement and Efficacy in a Rabbit Model of Microembolic Signals
- (2016) Christopher M. Barbieri et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells
- (2016) Kerstin Göbel et al. Nature Communications
- The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats
- (2016) Jennifer Krupka et al. PLoS One
- Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III
- (2015) Jenny Björkqvist et al. JOURNAL OF CLINICAL INVESTIGATION
- Factor XII: a novel target for safe prevention of thrombosis and inflammation
- (2015) E. Kenne et al. JOURNAL OF INTERNAL MEDICINE
- New Infestin-4 Mutants with Increased Selectivity against Factor XIIa
- (2015) Vladimir N. Kolyadko et al. PLoS One
- Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits
- (2014) Jonathan W. Yau et al. BLOOD
- A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
- (2014) M. Larsson et al. Science Translational Medicine
- C0265: A New Highly Selective Factor XIIA Inhibitor Based on Infestin-4
- (2014) V. Kolyadko et al. THROMBOSIS RESEARCH
- Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit
- (2013) Yiming Xu et al. THROMBOSIS AND HAEMOSTASIS
- The Kazal-type inhibitors infestins 1 and 4 differ in specificity but are similar in three-dimensional structure
- (2012) I. T. N. Campos et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- In vivo roles of factor XII
- (2012) T. Renne et al. BLOOD
- Factor XIIa Inhibitor Recombinant Human Albumin Infestin-4 Abolishes Occlusive Arterial Thrombus Formation Without Affecting Bleeding
- (2010) Ina Hagedorn et al. CIRCULATION
- Coagulation in Vertebrates with a Focus on Evolution and Inflammation
- (2010) Russell F. Doolittle Journal of Innate Immunity
- Structure and function of invertebrate Kazal-type serine proteinase inhibitors
- (2009) Vichien Rimphanitchayakit et al. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
- Ir-CPI, a coagulation contact phase inhibitor from the tickIxodes ricinus, inhibits thrombus formation without impairing hemostasis
- (2009) Yves Decrem et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment
- (2008) G. Stoll et al. BLOOD
- Pasteurized C1 inhibitor concentrate in hereditary angioedema: pharmacology, safety, efficacy and future directions
- (2007) Konrad Bork Expert Review of Clinical Immunology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started